nodes	percent_of_prediction	percent_of_DWPC	metapath
Estropipate—ALB—Vismodegib—skin cancer	0.121	0.158	CbGbCtD
Estropipate—CYP1A2—Imiquimod—skin cancer	0.105	0.136	CbGbCtD
Estropipate—ALB—Vemurafenib—skin cancer	0.096	0.125	CbGbCtD
Estropipate—CYP2C9—Vismodegib—skin cancer	0.0654	0.0851	CbGbCtD
Estropipate—CYP1A2—Vemurafenib—skin cancer	0.0574	0.0746	CbGbCtD
Estropipate—CYP3A4—Temozolomide—skin cancer	0.0549	0.0713	CbGbCtD
Estropipate—CYP3A4—Imiquimod—skin cancer	0.0549	0.0713	CbGbCtD
Estropipate—CYP1A2—Dacarbazine—skin cancer	0.044	0.0572	CbGbCtD
Estropipate—ALB—Fluorouracil—skin cancer	0.0431	0.056	CbGbCtD
Estropipate—CYP3A4—Vismodegib—skin cancer	0.038	0.0495	CbGbCtD
Estropipate—CYP3A4—Vemurafenib—skin cancer	0.0301	0.0391	CbGbCtD
Estropipate—CYP1A2—Fluorouracil—skin cancer	0.0258	0.0335	CbGbCtD
Estropipate—CYP2C9—Fluorouracil—skin cancer	0.0232	0.0302	CbGbCtD
Estropipate—CYP3A4—Docetaxel—skin cancer	0.0103	0.0134	CbGbCtD
Estropipate—SHBG—hindlimb—skin cancer	0.00297	0.196	CbGeAlD
Estropipate—ESR2—neck—skin cancer	0.00105	0.0689	CbGeAlD
Estropipate—SHBG—neck—skin cancer	0.00102	0.067	CbGeAlD
Estropipate—ESR1—blood vessel—skin cancer	0.001	0.066	CbGeAlD
Estropipate—ESR2—connective tissue—skin cancer	0.000749	0.0494	CbGeAlD
Estropipate—SHBG—connective tissue—skin cancer	0.000728	0.048	CbGeAlD
Estropipate—ESR1—neck—skin cancer	0.000716	0.0472	CbGeAlD
Estropipate—ESR2—epithelium—skin cancer	0.000711	0.0469	CbGeAlD
Estropipate—CYP1A2—nipple—skin cancer	0.000558	0.0368	CbGeAlD
Estropipate—ESR2—lymphoid tissue—skin cancer	0.000548	0.0361	CbGeAlD
Estropipate—Blood pressure increased—Docetaxel—skin cancer	0.000537	0.00249	CcSEcCtD
Estropipate—Pulmonary embolism—Docetaxel—skin cancer	0.000537	0.00249	CcSEcCtD
Estropipate—Breast disorder—Temozolomide—skin cancer	0.00053	0.00246	CcSEcCtD
Estropipate—ESR2—female reproductive system—skin cancer	0.000528	0.0348	CbGeAlD
Estropipate—Acute coronary syndrome—Bleomycin—skin cancer	0.000528	0.00245	CcSEcCtD
Estropipate—Myocardial infarction—Bleomycin—skin cancer	0.000525	0.00244	CcSEcCtD
Estropipate—Palpitations—Imiquimod—skin cancer	0.000521	0.00242	CcSEcCtD
Estropipate—Irritability—Fluorouracil—skin cancer	0.000516	0.00239	CcSEcCtD
Estropipate—Cough—Imiquimod—skin cancer	0.000514	0.00239	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.000514	0.00239	CcSEcCtD
Estropipate—SHBG—female reproductive system—skin cancer	0.000514	0.0338	CbGeAlD
Estropipate—ESR1—connective tissue—skin cancer	0.000513	0.0338	CbGeAlD
Estropipate—Abdominal distension—Temozolomide—skin cancer	0.00051	0.00237	CcSEcCtD
Estropipate—Fluid retention—Docetaxel—skin cancer	0.00051	0.00237	CcSEcCtD
Estropipate—Arthralgia—Imiquimod—skin cancer	0.000502	0.00233	CcSEcCtD
Estropipate—Myalgia—Imiquimod—skin cancer	0.000502	0.00233	CcSEcCtD
Estropipate—Anxiety—Imiquimod—skin cancer	0.0005	0.00232	CcSEcCtD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Imiquimod—skin cancer	0.000498	0.00231	CcSEcCtD
Estropipate—ESR1—epithelium—skin cancer	0.000487	0.0321	CbGeAlD
Estropipate—Gastrointestinal disorder—Vemurafenib—skin cancer	0.000487	0.00226	CcSEcCtD
Estropipate—Fatigue—Vemurafenib—skin cancer	0.000486	0.00226	CcSEcCtD
Estropipate—Neoplasm—Docetaxel—skin cancer	0.000486	0.00226	CcSEcCtD
Estropipate—Constipation—Vemurafenib—skin cancer	0.000482	0.00224	CcSEcCtD
Estropipate—Oedema—Imiquimod—skin cancer	0.000481	0.00223	CcSEcCtD
Estropipate—Infection—Imiquimod—skin cancer	0.000478	0.00222	CcSEcCtD
Estropipate—Dysuria—Temozolomide—skin cancer	0.000474	0.0022	CcSEcCtD
Estropipate—Nervous system disorder—Imiquimod—skin cancer	0.000472	0.00219	CcSEcCtD
Estropipate—Upper respiratory tract infection—Temozolomide—skin cancer	0.000471	0.00219	CcSEcCtD
Estropipate—Skin disorder—Imiquimod—skin cancer	0.000467	0.00217	CcSEcCtD
Estropipate—Weight increased—Temozolomide—skin cancer	0.000461	0.00214	CcSEcCtD
Estropipate—Hyperglycaemia—Temozolomide—skin cancer	0.000457	0.00212	CcSEcCtD
Estropipate—Infestation—Temozolomide—skin cancer	0.000452	0.0021	CcSEcCtD
Estropipate—Infestation NOS—Temozolomide—skin cancer	0.000452	0.0021	CcSEcCtD
Estropipate—Depression—Temozolomide—skin cancer	0.000451	0.00209	CcSEcCtD
Estropipate—Thrombophlebitis—Docetaxel—skin cancer	0.000451	0.00209	CcSEcCtD
Estropipate—Body temperature increased—Vemurafenib—skin cancer	0.000446	0.00207	CcSEcCtD
Estropipate—Pharyngitis—Dactinomycin—skin cancer	0.000445	0.00207	CcSEcCtD
Estropipate—Neuropathy peripheral—Temozolomide—skin cancer	0.000443	0.00206	CcSEcCtD
Estropipate—ESR2—head—skin cancer	0.000441	0.0291	CbGeAlD
Estropipate—Musculoskeletal discomfort—Imiquimod—skin cancer	0.000438	0.00203	CcSEcCtD
Estropipate—Insomnia—Imiquimod—skin cancer	0.000435	0.00202	CcSEcCtD
Estropipate—Upper respiratory tract infection—Fluorouracil—skin cancer	0.000434	0.00202	CcSEcCtD
Estropipate—Paraesthesia—Imiquimod—skin cancer	0.000432	0.00201	CcSEcCtD
Estropipate—Somnolence—Imiquimod—skin cancer	0.000428	0.00199	CcSEcCtD
Estropipate—Hepatobiliary disease—Temozolomide—skin cancer	0.000428	0.00198	CcSEcCtD
Estropipate—Alopecia—Bleomycin—skin cancer	0.000425	0.00197	CcSEcCtD
Estropipate—Erythema multiforme—Dactinomycin—skin cancer	0.000424	0.00197	CcSEcCtD
Estropipate—Sinusitis—Temozolomide—skin cancer	0.000424	0.00197	CcSEcCtD
Estropipate—Dyspepsia—Imiquimod—skin cancer	0.000424	0.00197	CcSEcCtD
Estropipate—Erythema—Bleomycin—skin cancer	0.000419	0.00194	CcSEcCtD
Estropipate—Infestation NOS—Fluorouracil—skin cancer	0.000417	0.00193	CcSEcCtD
Estropipate—Infestation—Fluorouracil—skin cancer	0.000417	0.00193	CcSEcCtD
Estropipate—Hypersensitivity—Vemurafenib—skin cancer	0.000416	0.00193	CcSEcCtD
Estropipate—Gastrointestinal disorder—Imiquimod—skin cancer	0.000415	0.00193	CcSEcCtD
Estropipate—Fatigue—Imiquimod—skin cancer	0.000415	0.00193	CcSEcCtD
Estropipate—Visual disturbance—Docetaxel—skin cancer	0.000412	0.00191	CcSEcCtD
Estropipate—Pain—Imiquimod—skin cancer	0.000411	0.00191	CcSEcCtD
Estropipate—Acute coronary syndrome—Fluorouracil—skin cancer	0.000411	0.00191	CcSEcCtD
Estropipate—Neuropathy peripheral—Fluorouracil—skin cancer	0.000408	0.0019	CcSEcCtD
Estropipate—Myocardial infarction—Fluorouracil—skin cancer	0.000408	0.0019	CcSEcCtD
Estropipate—Dermatitis bullous—Docetaxel—skin cancer	0.000408	0.00189	CcSEcCtD
Estropipate—Asthenia—Vemurafenib—skin cancer	0.000405	0.00188	CcSEcCtD
Estropipate—Pharyngitis—Temozolomide—skin cancer	0.000403	0.00187	CcSEcCtD
Estropipate—Oedema peripheral—Temozolomide—skin cancer	0.0004	0.00186	CcSEcCtD
Estropipate—Pruritus—Vemurafenib—skin cancer	0.000399	0.00185	CcSEcCtD
Estropipate—Alopecia—Dactinomycin—skin cancer	0.000397	0.00184	CcSEcCtD
Estropipate—Gastrointestinal pain—Imiquimod—skin cancer	0.000393	0.00183	CcSEcCtD
Estropipate—Visual impairment—Temozolomide—skin cancer	0.000391	0.00182	CcSEcCtD
Estropipate—Sinusitis—Fluorouracil—skin cancer	0.000391	0.00181	CcSEcCtD
Estropipate—Erythema—Dactinomycin—skin cancer	0.000391	0.00181	CcSEcCtD
Estropipate—Pain in extremity—Docetaxel—skin cancer	0.00039	0.00181	CcSEcCtD
Estropipate—Diarrhoea—Vemurafenib—skin cancer	0.000386	0.00179	CcSEcCtD
Estropipate—Migraine—Docetaxel—skin cancer	0.000384	0.00178	CcSEcCtD
Estropipate—Erythema multiforme—Temozolomide—skin cancer	0.000384	0.00178	CcSEcCtD
Estropipate—Urticaria—Imiquimod—skin cancer	0.000382	0.00177	CcSEcCtD
Estropipate—Abdominal pain—Imiquimod—skin cancer	0.00038	0.00177	CcSEcCtD
Estropipate—Body temperature increased—Imiquimod—skin cancer	0.00038	0.00177	CcSEcCtD
Estropipate—Eye disorder—Temozolomide—skin cancer	0.000379	0.00176	CcSEcCtD
Estropipate—Cardiac disorder—Temozolomide—skin cancer	0.000377	0.00175	CcSEcCtD
Estropipate—ESR1—lymphoid tissue—skin cancer	0.000375	0.0247	CbGeAlD
Estropipate—Rhinitis—Fluorouracil—skin cancer	0.000375	0.00174	CcSEcCtD
Estropipate—Dizziness—Vemurafenib—skin cancer	0.000373	0.00173	CcSEcCtD
Estropipate—Pharyngitis—Fluorouracil—skin cancer	0.000371	0.00172	CcSEcCtD
Estropipate—SLC22A1—head—skin cancer	0.00037	0.0244	CbGeAlD
Estropipate—Angiopathy—Temozolomide—skin cancer	0.000368	0.00171	CcSEcCtD
Estropipate—Immune system disorder—Temozolomide—skin cancer	0.000367	0.0017	CcSEcCtD
Estropipate—Mediastinal disorder—Temozolomide—skin cancer	0.000366	0.0017	CcSEcCtD
Estropipate—Cough—Bleomycin—skin cancer	0.000365	0.0017	CcSEcCtD
Estropipate—ESR1—female reproductive system—skin cancer	0.000362	0.0238	CbGeAlD
Estropipate—Vomiting—Vemurafenib—skin cancer	0.000359	0.00166	CcSEcCtD
Estropipate—Alopecia—Temozolomide—skin cancer	0.000359	0.00166	CcSEcCtD
Estropipate—Myalgia—Bleomycin—skin cancer	0.000357	0.00165	CcSEcCtD
Estropipate—Rash—Vemurafenib—skin cancer	0.000356	0.00165	CcSEcCtD
Estropipate—Mental disorder—Temozolomide—skin cancer	0.000356	0.00165	CcSEcCtD
Estropipate—Dermatitis—Vemurafenib—skin cancer	0.000355	0.00165	CcSEcCtD
Estropipate—Hypersensitivity—Imiquimod—skin cancer	0.000355	0.00165	CcSEcCtD
Estropipate—Headache—Vemurafenib—skin cancer	0.000353	0.00164	CcSEcCtD
Estropipate—Erythema—Temozolomide—skin cancer	0.000353	0.00164	CcSEcCtD
Estropipate—Malnutrition—Temozolomide—skin cancer	0.000353	0.00164	CcSEcCtD
Estropipate—Breast disorder—Docetaxel—skin cancer	0.000353	0.00164	CcSEcCtD
Estropipate—Cramp muscle—Docetaxel—skin cancer	0.000351	0.00163	CcSEcCtD
Estropipate—Asthenia—Imiquimod—skin cancer	0.000345	0.0016	CcSEcCtD
Estropipate—Anaphylactic shock—Bleomycin—skin cancer	0.000342	0.00159	CcSEcCtD
Estropipate—Oedema—Bleomycin—skin cancer	0.000342	0.00159	CcSEcCtD
Estropipate—Back pain—Temozolomide—skin cancer	0.000342	0.00159	CcSEcCtD
Estropipate—Pruritus—Imiquimod—skin cancer	0.00034	0.00158	CcSEcCtD
Estropipate—Infection—Bleomycin—skin cancer	0.00034	0.00158	CcSEcCtD
Estropipate—Nausea—Vemurafenib—skin cancer	0.000335	0.00156	CcSEcCtD
Estropipate—Myalgia—Dactinomycin—skin cancer	0.000333	0.00154	CcSEcCtD
Estropipate—Alopecia—Fluorouracil—skin cancer	0.00033	0.00153	CcSEcCtD
Estropipate—Diarrhoea—Imiquimod—skin cancer	0.000329	0.00153	CcSEcCtD
Estropipate—Erythema—Fluorouracil—skin cancer	0.000326	0.00151	CcSEcCtD
Estropipate—Angioedema—Temozolomide—skin cancer	0.000323	0.0015	CcSEcCtD
Estropipate—Oedema—Dactinomycin—skin cancer	0.000319	0.00148	CcSEcCtD
Estropipate—Dizziness—Imiquimod—skin cancer	0.000318	0.00148	CcSEcCtD
Estropipate—Vertigo—Temozolomide—skin cancer	0.000317	0.00147	CcSEcCtD
Estropipate—Infection—Dactinomycin—skin cancer	0.000317	0.00147	CcSEcCtD
Estropipate—Palpitations—Temozolomide—skin cancer	0.000312	0.00145	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000311	0.00145	CcSEcCtD
Estropipate—ESR2—lymph node—skin cancer	0.000309	0.0204	CbGeAlD
Estropipate—Cough—Temozolomide—skin cancer	0.000308	0.00143	CcSEcCtD
Estropipate—Paraesthesia—Bleomycin—skin cancer	0.000307	0.00142	CcSEcCtD
Estropipate—Weight increased—Docetaxel—skin cancer	0.000307	0.00142	CcSEcCtD
Estropipate—Vomiting—Imiquimod—skin cancer	0.000306	0.00142	CcSEcCtD
Estropipate—Rash—Imiquimod—skin cancer	0.000303	0.00141	CcSEcCtD
Estropipate—Dermatitis—Imiquimod—skin cancer	0.000303	0.00141	CcSEcCtD
Estropipate—ESR1—head—skin cancer	0.000302	0.0199	CbGeAlD
Estropipate—Headache—Imiquimod—skin cancer	0.000301	0.0014	CcSEcCtD
Estropipate—Myalgia—Temozolomide—skin cancer	0.000301	0.0014	CcSEcCtD
Estropipate—Arthralgia—Temozolomide—skin cancer	0.000301	0.0014	CcSEcCtD
Estropipate—Infestation—Docetaxel—skin cancer	0.000301	0.0014	CcSEcCtD
Estropipate—Infestation NOS—Docetaxel—skin cancer	0.000301	0.0014	CcSEcCtD
Estropipate—Anxiety—Temozolomide—skin cancer	0.0003	0.00139	CcSEcCtD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000299	0.00139	CcSEcCtD
Estropipate—Acute coronary syndrome—Docetaxel—skin cancer	0.000296	0.00138	CcSEcCtD
Estropipate—Myocardial infarction—Docetaxel—skin cancer	0.000295	0.00137	CcSEcCtD
Estropipate—Neuropathy peripheral—Docetaxel—skin cancer	0.000295	0.00137	CcSEcCtD
Estropipate—Pain—Bleomycin—skin cancer	0.000292	0.00136	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.00029	0.00135	CcSEcCtD
Estropipate—Oedema—Temozolomide—skin cancer	0.000288	0.00134	CcSEcCtD
Estropipate—Anaphylactic shock—Temozolomide—skin cancer	0.000288	0.00134	CcSEcCtD
Estropipate—Infection—Temozolomide—skin cancer	0.000286	0.00133	CcSEcCtD
Estropipate—Nausea—Imiquimod—skin cancer	0.000286	0.00133	CcSEcCtD
Estropipate—Hepatobiliary disease—Docetaxel—skin cancer	0.000284	0.00132	CcSEcCtD
Estropipate—Nervous system disorder—Temozolomide—skin cancer	0.000283	0.00131	CcSEcCtD
Estropipate—Skin disorder—Temozolomide—skin cancer	0.00028	0.0013	CcSEcCtD
Estropipate—Myalgia—Fluorouracil—skin cancer	0.000277	0.00129	CcSEcCtD
Estropipate—Fatigue—Dactinomycin—skin cancer	0.000275	0.00128	CcSEcCtD
Estropipate—Pain—Dactinomycin—skin cancer	0.000273	0.00127	CcSEcCtD
Estropipate—Urticaria—Bleomycin—skin cancer	0.000272	0.00126	CcSEcCtD
Estropipate—Rhinitis—Docetaxel—skin cancer	0.000271	0.00126	CcSEcCtD
Estropipate—Body temperature increased—Bleomycin—skin cancer	0.00027	0.00125	CcSEcCtD
Estropipate—Pharyngitis—Docetaxel—skin cancer	0.000268	0.00124	CcSEcCtD
Estropipate—Oedema peripheral—Docetaxel—skin cancer	0.000266	0.00123	CcSEcCtD
Estropipate—Anaphylactic shock—Fluorouracil—skin cancer	0.000266	0.00123	CcSEcCtD
Estropipate—Oedema—Fluorouracil—skin cancer	0.000266	0.00123	CcSEcCtD
Estropipate—CYP2C9—female reproductive system—skin cancer	0.000265	0.0175	CbGeAlD
Estropipate—Infection—Fluorouracil—skin cancer	0.000264	0.00122	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000263	0.00122	CcSEcCtD
Estropipate—Insomnia—Temozolomide—skin cancer	0.000261	0.00121	CcSEcCtD
Estropipate—Gastrointestinal pain—Dactinomycin—skin cancer	0.000261	0.00121	CcSEcCtD
Estropipate—Nervous system disorder—Fluorouracil—skin cancer	0.000261	0.00121	CcSEcCtD
Estropipate—Visual impairment—Docetaxel—skin cancer	0.00026	0.00121	CcSEcCtD
Estropipate—Paraesthesia—Temozolomide—skin cancer	0.000259	0.0012	CcSEcCtD
Estropipate—Somnolence—Temozolomide—skin cancer	0.000256	0.00119	CcSEcCtD
Estropipate—Erythema multiforme—Docetaxel—skin cancer	0.000255	0.00118	CcSEcCtD
Estropipate—Dyspepsia—Temozolomide—skin cancer	0.000254	0.00118	CcSEcCtD
Estropipate—Eye disorder—Docetaxel—skin cancer	0.000252	0.00117	CcSEcCtD
Estropipate—Abdominal pain—Dactinomycin—skin cancer	0.000252	0.00117	CcSEcCtD
Estropipate—Body temperature increased—Dactinomycin—skin cancer	0.000252	0.00117	CcSEcCtD
Estropipate—Hypersensitivity—Bleomycin—skin cancer	0.000252	0.00117	CcSEcCtD
Estropipate—Cardiac disorder—Docetaxel—skin cancer	0.00025	0.00116	CcSEcCtD
Estropipate—Gastrointestinal disorder—Temozolomide—skin cancer	0.000249	0.00116	CcSEcCtD
Estropipate—Fatigue—Temozolomide—skin cancer	0.000249	0.00115	CcSEcCtD
Estropipate—ALB—lymph node—skin cancer	0.000248	0.0164	CbGeAlD
Estropipate—Pain—Temozolomide—skin cancer	0.000247	0.00114	CcSEcCtD
Estropipate—Constipation—Temozolomide—skin cancer	0.000247	0.00114	CcSEcCtD
Estropipate—Asthenia—Bleomycin—skin cancer	0.000245	0.00114	CcSEcCtD
Estropipate—Angiopathy—Docetaxel—skin cancer	0.000245	0.00114	CcSEcCtD
Estropipate—Immune system disorder—Docetaxel—skin cancer	0.000244	0.00113	CcSEcCtD
Estropipate—Mediastinal disorder—Docetaxel—skin cancer	0.000243	0.00113	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000242	0.00112	CcSEcCtD
Estropipate—Pruritus—Bleomycin—skin cancer	0.000242	0.00112	CcSEcCtD
Estropipate—Insomnia—Fluorouracil—skin cancer	0.00024	0.00112	CcSEcCtD
Estropipate—Paraesthesia—Fluorouracil—skin cancer	0.000239	0.00111	CcSEcCtD
Estropipate—Alopecia—Docetaxel—skin cancer	0.000239	0.00111	CcSEcCtD
Estropipate—Mental disorder—Docetaxel—skin cancer	0.000236	0.0011	CcSEcCtD
Estropipate—Somnolence—Fluorouracil—skin cancer	0.000236	0.0011	CcSEcCtD
Estropipate—Gastrointestinal pain—Temozolomide—skin cancer	0.000236	0.00109	CcSEcCtD
Estropipate—Malnutrition—Docetaxel—skin cancer	0.000235	0.00109	CcSEcCtD
Estropipate—Erythema—Docetaxel—skin cancer	0.000235	0.00109	CcSEcCtD
Estropipate—Hypersensitivity—Dactinomycin—skin cancer	0.000235	0.00109	CcSEcCtD
Estropipate—Dyspepsia—Fluorouracil—skin cancer	0.000234	0.00109	CcSEcCtD
Estropipate—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000229	0.00106	CcSEcCtD
Estropipate—Urticaria—Temozolomide—skin cancer	0.000229	0.00106	CcSEcCtD
Estropipate—Asthenia—Dactinomycin—skin cancer	0.000229	0.00106	CcSEcCtD
Estropipate—Abdominal pain—Temozolomide—skin cancer	0.000228	0.00106	CcSEcCtD
Estropipate—Body temperature increased—Temozolomide—skin cancer	0.000228	0.00106	CcSEcCtD
Estropipate—Back pain—Docetaxel—skin cancer	0.000227	0.00105	CcSEcCtD
Estropipate—Pain—Fluorouracil—skin cancer	0.000227	0.00105	CcSEcCtD
Estropipate—Muscle spasms—Docetaxel—skin cancer	0.000226	0.00105	CcSEcCtD
Estropipate—Diarrhoea—Dactinomycin—skin cancer	0.000218	0.00101	CcSEcCtD
Estropipate—Vomiting—Bleomycin—skin cancer	0.000217	0.00101	CcSEcCtD
Estropipate—Rash—Bleomycin—skin cancer	0.000216	0.001	CcSEcCtD
Estropipate—Dermatitis—Bleomycin—skin cancer	0.000215	0.000999	CcSEcCtD
Estropipate—Hypersensitivity—Temozolomide—skin cancer	0.000212	0.000986	CcSEcCtD
Estropipate—ESR1—lymph node—skin cancer	0.000212	0.014	CbGeAlD
Estropipate—Urticaria—Fluorouracil—skin cancer	0.000211	0.00098	CcSEcCtD
Estropipate—Body temperature increased—Fluorouracil—skin cancer	0.00021	0.000975	CcSEcCtD
Estropipate—Palpitations—Docetaxel—skin cancer	0.000208	0.000964	CcSEcCtD
Estropipate—Asthenia—Temozolomide—skin cancer	0.000207	0.00096	CcSEcCtD
Estropipate—Cough—Docetaxel—skin cancer	0.000205	0.000952	CcSEcCtD
Estropipate—Pruritus—Temozolomide—skin cancer	0.000204	0.000947	CcSEcCtD
Estropipate—Nausea—Bleomycin—skin cancer	0.000203	0.000942	CcSEcCtD
Estropipate—Vomiting—Dactinomycin—skin cancer	0.000203	0.000941	CcSEcCtD
Estropipate—CYP3A4—female reproductive system—skin cancer	0.000202	0.0133	CbGeAlD
Estropipate—Rash—Dactinomycin—skin cancer	0.000201	0.000933	CcSEcCtD
Estropipate—Arthralgia—Docetaxel—skin cancer	0.0002	0.000928	CcSEcCtD
Estropipate—Myalgia—Docetaxel—skin cancer	0.0002	0.000928	CcSEcCtD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000199	0.000922	CcSEcCtD
Estropipate—Diarrhoea—Temozolomide—skin cancer	0.000197	0.000916	CcSEcCtD
Estropipate—Hypersensitivity—Fluorouracil—skin cancer	0.000196	0.000908	CcSEcCtD
Estropipate—Oedema—Docetaxel—skin cancer	0.000192	0.00089	CcSEcCtD
Estropipate—Anaphylactic shock—Docetaxel—skin cancer	0.000192	0.00089	CcSEcCtD
Estropipate—Dizziness—Temozolomide—skin cancer	0.000191	0.000885	CcSEcCtD
Estropipate—Infection—Docetaxel—skin cancer	0.000191	0.000884	CcSEcCtD
Estropipate—Nausea—Dactinomycin—skin cancer	0.000189	0.000879	CcSEcCtD
Estropipate—Nervous system disorder—Docetaxel—skin cancer	0.000188	0.000873	CcSEcCtD
Estropipate—Pruritus—Fluorouracil—skin cancer	0.000188	0.000872	CcSEcCtD
Estropipate—Skin disorder—Docetaxel—skin cancer	0.000186	0.000864	CcSEcCtD
Estropipate—Vomiting—Temozolomide—skin cancer	0.000183	0.000851	CcSEcCtD
Estropipate—Rash—Temozolomide—skin cancer	0.000182	0.000844	CcSEcCtD
Estropipate—Diarrhoea—Fluorouracil—skin cancer	0.000182	0.000844	CcSEcCtD
Estropipate—Dermatitis—Temozolomide—skin cancer	0.000182	0.000843	CcSEcCtD
Estropipate—Headache—Temozolomide—skin cancer	0.000181	0.000838	CcSEcCtD
Estropipate—Dizziness—Fluorouracil—skin cancer	0.000176	0.000815	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000175	0.000811	CcSEcCtD
Estropipate—Insomnia—Docetaxel—skin cancer	0.000173	0.000805	CcSEcCtD
Estropipate—Paraesthesia—Docetaxel—skin cancer	0.000172	0.000799	CcSEcCtD
Estropipate—Nausea—Temozolomide—skin cancer	0.000171	0.000795	CcSEcCtD
Estropipate—Somnolence—Docetaxel—skin cancer	0.00017	0.000791	CcSEcCtD
Estropipate—Vomiting—Fluorouracil—skin cancer	0.000169	0.000784	CcSEcCtD
Estropipate—Dyspepsia—Docetaxel—skin cancer	0.000169	0.000783	CcSEcCtD
Estropipate—Rash—Fluorouracil—skin cancer	0.000168	0.000777	CcSEcCtD
Estropipate—Dermatitis—Fluorouracil—skin cancer	0.000167	0.000777	CcSEcCtD
Estropipate—Headache—Fluorouracil—skin cancer	0.000166	0.000772	CcSEcCtD
Estropipate—Gastrointestinal disorder—Docetaxel—skin cancer	0.000166	0.000768	CcSEcCtD
Estropipate—Fatigue—Docetaxel—skin cancer	0.000165	0.000767	CcSEcCtD
Estropipate—Pain—Docetaxel—skin cancer	0.000164	0.000761	CcSEcCtD
Estropipate—Constipation—Docetaxel—skin cancer	0.000164	0.000761	CcSEcCtD
Estropipate—Nausea—Fluorouracil—skin cancer	0.000158	0.000732	CcSEcCtD
Estropipate—Gastrointestinal pain—Docetaxel—skin cancer	0.000157	0.000728	CcSEcCtD
Estropipate—Abdominal pain—Docetaxel—skin cancer	0.000152	0.000704	CcSEcCtD
Estropipate—Body temperature increased—Docetaxel—skin cancer	0.000152	0.000704	CcSEcCtD
Estropipate—Hypersensitivity—Docetaxel—skin cancer	0.000141	0.000656	CcSEcCtD
Estropipate—Asthenia—Docetaxel—skin cancer	0.000138	0.000639	CcSEcCtD
Estropipate—Pruritus—Docetaxel—skin cancer	0.000136	0.00063	CcSEcCtD
Estropipate—Diarrhoea—Docetaxel—skin cancer	0.000131	0.000609	CcSEcCtD
Estropipate—Dizziness—Docetaxel—skin cancer	0.000127	0.000589	CcSEcCtD
Estropipate—Vomiting—Docetaxel—skin cancer	0.000122	0.000566	CcSEcCtD
Estropipate—Rash—Docetaxel—skin cancer	0.000121	0.000561	CcSEcCtD
Estropipate—Dermatitis—Docetaxel—skin cancer	0.000121	0.000561	CcSEcCtD
Estropipate—Headache—Docetaxel—skin cancer	0.00012	0.000558	CcSEcCtD
Estropipate—Nausea—Docetaxel—skin cancer	0.000114	0.000529	CcSEcCtD
